Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Lantern Pharma Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 25 | 33 | +8 |
| Shares | 1.40M | 1.66M | +257.8K (+18.4%) |
| Value | $15.7M | $13.1M | −$2.54M (−16.2%) |
New holders (13)
Institutions that held Lantern Pharma Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sanders Morris Harris LLC | 336,425 | $2.57M | 0.45% |
| Carlson Capital L P | 125,000 | $998.0K | 0.06% |
| Two Sigma Investments, LP | 69,611 | $555.0K | 0.00% |
| Anson Funds Management LP | 64,999 | $519.0K | 0.07% |
| Lynwood Capital Management Inc. | 50,000 | $399.0K | 0.38% |
| Trexquant Investment LP | 27,970 | $223.0K | 0.01% |
| Two Sigma Advisers, LP | 25,300 | $202.0K | 0.00% |
| Sigma Planning Corp | 17,600 | $140.0K | 0.00% |
| Citadel Advisors LLC | 11,095 | $89.0K | 0.00% |
| Jump Financial, LLC | 11,028 | $88.0K | 0.01% |
| Envestnet Asset Management Inc | 10,542 | $84.0K | 0.00% |
| JPMorgan Chase & Co | 5,250 | $42.0K | 0.00% |
| Royal Bank of Canada | 24 | $0 | 0.00% |
Sold out (5)
Institutions that held Lantern Pharma Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Corriente Advisors, LLC | 625,873 | $7.00M |
| Raymond James & Associates | 25,879 | $289.0K |
| US Bancorp | 2,000 | $22.0K |
| AdvisorNet Financial, Inc | 500 | $6.00K |
| Harbour Investments, Inc. | 31 | $0 |